To investigate the effects of PRMT1 methyltransferase activity and macrophage polarization on gastric cancer progression in vivo, we conducted experiments using the PRMT1 enzymatic activity inhibitor MS023 and the macrophage-depleting agent clodronate liposomes. This evidence concerns the gene PRMT1 and gastric cancer.